sialix-dv-farma
overview

Regulatory status Dietary supplement

IP Assets

n/a

Distribuito / In registrazione in

Italy

Forma farmaceutica

Capsule

Punti di Forza

Blend of innovative ingredients Patent pending Registered trademark Clinically proven efficacy

Glaucoma is a neurodegenerative disease characterized by progressive damage to retinal ganglion cells and the optic nerve, which can lead to irreversible vision loss.
An increase in intraocular pressure (IOP) is not a direct etiopathogenetic factor, but it represents the main risk factor and a key element in the progression of glaucoma.
In addition to ocular hypertension, oxidative stress, microvascular disorders, and impairment of neuroprotective mechanisms also contribute to retinal damage.

prodotti correlati
  • UNDER DEVELOPMENT

    DVDS4

    Designed for patients affected by or at risk of diabetic serous chorioretinopathy. It stimulates the physiological processes involved in cortisol regulation and protects retinal pigment epithelial and ganglion cells.

    ,
  • nattolux-dv-farma

    NATTOLUX

    The vitreous body is a gel-like substance that helps maintain the shape of the eye and the transmission of light. NATTOLUX is a dietary supplement with targeted active ingredients designed to support vitreous health and counteract the alterations that lead to floaters (myodesopsia) and posterior vitreous detachment.